Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC).

Joshua Linscott,Scott Michael Gilbert,Kyle M Rose,Wade J Sexton,Logan Zemp,Prithvi Murthy,Pan Du,Lucia P Camperlengo,Hiroko Miyagi,Shidong Jia,Giancarlo Bonora,Billie Gould,Roger Li,Philippe E Spiess,Joshua J Meeks

doi:10.1200/jco.2024.42.16_suppl.4600

Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC).

Joshua Linscott, Scott Michael Gilbert + Show 13 more

https://doi.org/10.1200/jco.2024.42.16_suppl.4600

Copy DOI

Export

Save

Cite

Journal: Journal of Clinical Oncology

Publication Date: Jun 1, 2024

#High-risk Non-muscle Invasive Bladder Cancer #Copy Number Burden #Urinary Cell-free DNA #Resection In Bladder Cancer #Urinary DNA #Urinary Tumor #Resection In Cancer #Cell-free DNA #Fraction Number #High-risk Cancer

Abstract
Full-Text
Similar Papers

Abstract

Listen

Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC).

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC).